Inventor · disambiguated record
Galit Rotman
Also filed as: ROTMAN GALIT
13 granted patents·34 pending applications·51 citations·filing 2003–2020
90Inventor score
Top patents by PatentIndex Score
47 records- 0186US7939634B2Polynucleotides encoding polypeptides and methods using sameCOMPUGEN LTD·Filed 2005·Granted May 10, 2011·9 cites·5 claims
- 0285US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0384US9617336B2C10RF32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Granted Apr 11, 2017·14 cites·23 claims
- 0484US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0582US7884180B2Peptides which bind to G protein-coupled receptorsCOMPUGEN LTD·Filed 2007·Granted Feb 8, 2011·4 cites·16 claims
- 0681US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0778US8349801B2Peptide ligands for G-protein coupled receptorsCOMPUGEN LTD·Filed 2007·Granted Jan 8, 2013·2 cites·12 claims
- 0878US7678769B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2007·Granted Mar 16, 2010·1 cites·6 claims
- 0974US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 1073US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 1173US7758862B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2006·Granted Jul 20, 2010·2 cites·16 claims
- 1269US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 1369US2022315641A9Polypeptides and uses thereof for treatment of autoimmune disorders and infectionCOMPUGEN LTD·Filed 2020·Application pending·0 cites
- 1463US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 1563US2005009771A1Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing sameFiled 2004·Application pending·0 cites
- 1661US2015005227A1Method of treating an ischemia-reperfusion injury-related disorder by administering gpcr ligandsCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 1759US2020002416A1C10rf32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2019·Application pending·0 cites
- 1859US2003228618A1Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing sameFiled 2003·Application pending·0 cites
- 1958US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2058US2019248866A1Polypeptides and uses thereof for treatment of autoimmune disorders and infectionCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 2157US9428574B2Polypeptides and uses thereof for treatment of autoimmune disorders and infectionTOPORIK AMIR·Filed 2012·Granted Aug 30, 2016·0 cites·21 claims
- 2257US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 2356US8828940B2Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligandsCOHEN YOSSI·Filed 2010·Granted Sep 9, 2014·0 cites·9 claims
- 2456US2004248157A1Novel polynucleotides encoding soluble polypeptides and methods using sameFiled 2004·Application pending·0 cites
- 2556US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 2655US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2754US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 2852US2016304579A1Polypeptides and uses thereof for treatment of autoimmune disorders and infectionCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2951US2005118615A1Chordin-like homologsCOMPUGEN LTD·Filed 2004·Application pending·0 cites
- 3050US2007219125A1Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using sameCOJOCARU GAD S·Filed 2007·Application pending·0 cites
- 3149US2005159590A1Variants of interleukin-1 receptor antagonist: compositions and uses thereofFiled 2004·Application pending·0 cites
- 3249US2019231848A1Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disordersCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 3349US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 3448US2005123538A1Polynucleotides encoding novel ErbB-2 polypeptides and kits and methods using sameFiled 2004·Application pending·0 cites
- 3545US2017233473A1C10rf32 antibodies, and uses thereof for treatment of cancerCOJOCARU GADY S·Filed 2017·Application pending·0 cites
- 3645US2006127901A1Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancersCOMPUGEN LTD·Filed 2003·Application pending·0 cites
- 3744US2011212051A1Variants of vascular endothelial growth factor (vegf) receptor and use thereofCOMPUGEN LTD·Filed 2011·Application pending·0 cites
- 3843US2013209463A1Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disordersROTMAN GALIT·Filed 2011·Application pending·0 cites
- 3942US2019309044A1Polypeptides and uses thereof as a drug for treatment of autoimmune disordersCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 4041US2005186600A1Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using sameFiled 2005·Application pending·0 cites
- 4140US2014294765A1Lsr antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 4239US2016347814A1Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4339US2017232062A1Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disordersROTMAN GALIT·Filed 2016·Application pending·0 cites
- 4436US2010183573A1Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2010·Application pending·0 cites
- 4532US2005281815A1CD40 splice variants and their usesESHEL DANI·Filed 2005·Application pending·0 cites
- 4632US2017275344A1Polypeptides and uses thereof as a drug for treatment of autoimmune disordersCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 4730US2006287229A1Novel CD40 variantsESHEL DANI·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Galit Rotman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →